Qiagen (QGEN) free cash flow

Free cash flow · fiscal 2025
$447.20M

Qiagen (QGEN) generated free cash flow of $447.20M in fiscal 2025 (the year ended December 31, 2025). That is 11.0% lower than the $502.31M of fiscal 2024. Figures as of 18 Nov 2026, 12:03 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$447.20M
Change on fiscal 2024
−11.0%
Growth, 5 years
+6.6% a year
Growth, 10 years
+7.4% a year
Highest on record
$565.93Mfiscal 2022
Lowest on record
$133.55Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Qiagen free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 6.6% a year; over ten years the rate was 7.4% a year. Across the 18 fiscal years on record (2008–2025), the highest was $565.93M in fiscal 2022 and the lowest $133.55M in fiscal 2008.

History · 18 fiscal years

Free cash flow by fiscal year

Qiagen free cash flow, year by year

Qiagen (QGEN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$447.20M 11.0% down
2024$502.31M 69.3% up
2023$296.65M 47.6% down
2022$565.93M 26.0% up
2021$449.10M 38.2% up
2020$325.02M 52.7% up
2019$212.89M 14.7% down
2018$249.72M 27.0% up
2017$196.70M 26.3% down
2016$267.07M 21.5% up
2015$219.72M 9.1% up
2014$201.37M 15.4% up
2013$174.49M 22.1% up
2012$142.88M 9.6% down
2011$157.97M 7.7% down
2010$171.09M 3.8% up
2009$164.82M 23.4% up
2008$133.55M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Qiagen and comparable companies
CompanyFree cash flowFiscal year
Vaxcyte PCVX-$712.55M2025
Bio-Rad Laboratories BIO$374.60M2025
Molina Healthcare MOH-$636.00M2025
Spyre Therapeutics SYRE-$169.25M2025
Qiagen QGEN$447.20M2025
Insulet PODD$349.90M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on QGEN

Qiagen, figure by figure

Qiagen (QGEN) overview: price, valuation and scorecardAll health care companies by market value

Qiagen free cash flow: questions and answers

What is Qiagen's free cash flow?

Qiagen (QGEN) generated free cash flow of $447.20M in fiscal 2025 (the year ended December 31, 2025). That is 11.0% lower than the $502.31M of fiscal 2024.

What is the growth rate of Qiagen's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 6.6% a year; over ten years the rate was 7.4% a year.

What are the highest and lowest free cash flow figures on record for Qiagen?

Across the 18 fiscal years on record (2008–2025), the highest was $565.93M in fiscal 2022 and the lowest $133.55M in fiscal 2008.

How is Qiagen's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Qiagen it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Qiagen (QGEN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/QGEN/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.